End-of-day quote
Mexican S.E.
07:00:00 2024-03-26 pm EDT
5-day change
1st Jan Change
15.78
MXN
+1.61%
+5.98%
+11.44%
Sales 2023
16.47B
993M
Sales 2024 *
18.09B
1.09B
Capitalization
14.67B
884M
Net income 2023
1.03B
62.15M
Net income 2024 *
2.3B
139M
EV / Sales 2023
1.07
x
Net Debt
2023
4.52B
272M
Net Debt
2024
*
1.97B
119M
EV / Sales 2024 *
0.9
x P/E ratio 2023
13.1
x
P/E ratio 2024 *
7.17
x
Employees
1,783
Yield 2023
1.38%
Yield 2024 *
0.98%
Free-Float
69.81%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Genomma Lab Internacional, S.A.B. De C.V. Declares Cash Dividend
Mar. 13
CI
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q4 2023 Earnings Call, Feb 22, 2024
Feb. 22
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 21
CI
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 21
CI
Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend Payment
Dec. 13
CI
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America
Nov. 29
CI
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q3 2023 Earnings Call, Oct 26, 2023
23-10-26
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-24
CI
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q2 2023 Earnings Call, Jul 27, 2023
23-07-27
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-07-26
CI
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q1 2023 Earnings Call, Apr 27, 2023
23-04-27
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-27
CI
Transcript : Genomma Lab Internacional, S.A.B. de C.V. - Analyst/Investor Day
23-03-08
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q4 2022 Earnings Call, Feb 23, 2023
23-02-23
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
23-02-22
CI
More news
1 day +1.61%
1 week +5.98%
Current month +19.91%
1 month +13.28%
3 months +9.43%
6 months +13.36%
Current year +11.44%
More quotes
Managers
Title Age Since
Chief Executive Officer
-
-
Founder
-
96-10-29
Director of Finance/CFO
-
-
Members of the board
Title Age Since
Director/Board Member
70
18-04-17
Founder
-
96-10-29
Director/Board Member
-
97-12-31
More insiders
Date
Price
Change
Volume
24-03-27
15.78
+1.61%
2,956,863
24-03-26
15.53
+0.45%
2,370,549
24-03-25
15.46
+2.45%
4,433,692
24-03-22
15.09
-1.11%
2,253,847
24-03-21
15.26
+2.48%
2,608,205
End-of-day quote
Mexican S.E., March 26, 2024
More quotes
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company's product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.
More about the company
Last Close Price
15.78
MXN
Average target price
21.11
MXN
Spread / Average Target
+33.80%
Consensus
1st Jan change
Capi.
+11.44% 888M +33.50% 701B +26.24% 571B +0.78% 381B +20.85% 334B +16.38% 319B +2.70% 210B +1.02% 210B -6.69% 201B -3.51% 157B
Other Pharmaceuticals
Stock Equities
Stock Genomma Lab Internacional, S.A.B. de C.V. - Mexican S.E.
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1